Cellectar Biosciences, Inc. (CLRB)
2.40
-0.01
(-0.41%)
USD |
NASDAQ |
Sep 09, 12:39
Cellectar Biosciences Price to Book Value : 0.6630 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.6658 |
| September 04, 2026 | 0.6547 |
| September 03, 2026 | 0.6492 |
| September 02, 2026 | 0.6713 |
| September 01, 2026 | 0.6796 |
| August 31, 2026 | 0.6934 |
| August 28, 2026 | 0.6989 |
| August 27, 2026 | 0.7017 |
| August 26, 2026 | 0.7017 |
| August 25, 2026 | 0.7017 |
| August 24, 2026 | 0.6962 |
| August 21, 2026 | 0.7155 |
| August 20, 2026 | 0.7155 |
| August 19, 2026 | 0.7238 |
| August 18, 2026 | 0.7155 |
| August 17, 2026 | 0.7072 |
| August 14, 2026 | 0.7183 |
| August 13, 2026 | 0.6851 |
| August 12, 2026 | 0.7183 |
| August 11, 2026 | 0.7293 |
| August 10, 2026 | 0.7183 |
| August 07, 2026 | 0.71 |
| August 06, 2026 | 0.6962 |
| August 05, 2026 | 0.6962 |
| August 04, 2026 | 0.7072 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.7348 |
| July 31, 2026 | 0.71 |
| July 30, 2026 | 0.6989 |
| July 29, 2026 | 0.6851 |
| July 28, 2026 | 0.6906 |
| July 27, 2026 | 0.6685 |
| July 24, 2026 | 0.6658 |
| July 23, 2026 | 0.6823 |
| July 22, 2026 | 0.6823 |
| July 21, 2026 | 0.7127 |
| July 20, 2026 | 0.6962 |
| July 17, 2026 | 0.6934 |
| July 16, 2026 | 0.7127 |
| July 15, 2026 | 0.721 |
| July 14, 2026 | 0.7265 |
| July 13, 2026 | 0.7265 |
| July 10, 2026 | 0.779 |
| July 09, 2026 | 0.7652 |
| July 08, 2026 | 0.7431 |
| July 07, 2026 | 0.7459 |
| July 06, 2026 | 0.7652 |
| July 02, 2026 | 0.7763 |
| July 01, 2026 | 0.7818 |
| June 30, 2026 | 0.768 |
| June 29, 2026 | 3.917 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.653 |
| Alnylam Pharmaceuticals, Inc. | 25.25 |
| Anika Therapeutics, Inc. | 2.043 |
| Savara, Inc. | 7.692 |
| Vericel Corp. | 5.368 |
Price to Book Value Related Metrics
| Price | 2.40 |
| Earnings Yield | -189.8% |
| Market Cap | 19.81M |